nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0647	0.11	CbGbCtD
Caffeine—CYP3A7—Ifosfamide—testicular cancer	0.0647	0.11	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—testicular cancer	0.0601	0.102	CbGbCtD
Caffeine—CYP3A5—Ifosfamide—testicular cancer	0.0485	0.0823	CbGbCtD
Caffeine—CYP2C8—Ifosfamide—testicular cancer	0.0467	0.0791	CbGbCtD
Caffeine—CYP2C9—Ifosfamide—testicular cancer	0.0326	0.0552	CbGbCtD
Caffeine—CYP2E1—Etoposide—testicular cancer	0.0299	0.0506	CbGbCtD
Caffeine—ABCB1—Dactinomycin—testicular cancer	0.0268	0.0454	CbGbCtD
Caffeine—CYP3A5—Etoposide—testicular cancer	0.0232	0.0393	CbGbCtD
Caffeine—CYP2C8—Etoposide—testicular cancer	0.0223	0.0378	CbGbCtD
Caffeine—CYP3A4—Ifosfamide—testicular cancer	0.0189	0.0321	CbGbCtD
Caffeine—CYP1A2—Etoposide—testicular cancer	0.0173	0.0293	CbGbCtD
Caffeine—ABCB1—Vinblastine—testicular cancer	0.0168	0.0284	CbGbCtD
Caffeine—CYP2C9—Cisplatin—testicular cancer	0.0158	0.0269	CbGbCtD
Caffeine—CYP2D6—Vinblastine—testicular cancer	0.0158	0.0268	CbGbCtD
Caffeine—ABCB1—Cisplatin—testicular cancer	0.0154	0.0261	CbGbCtD
Caffeine—ABCB1—Etoposide—testicular cancer	0.0151	0.0256	CbGbCtD
Caffeine—ABCB1—Doxorubicin—testicular cancer	0.0103	0.0175	CbGbCtD
Caffeine—CYP3A4—Vinblastine—testicular cancer	0.01	0.017	CbGbCtD
Caffeine—ABCB1—Methotrexate—testicular cancer	0.00998	0.0169	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—testicular cancer	0.0097	0.0165	CbGbCtD
Caffeine—CYP3A4—Etoposide—testicular cancer	0.00905	0.0153	CbGbCtD
Caffeine—ATM—embryo—testicular cancer	0.00691	0.0599	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—testicular cancer	0.00617	0.0105	CbGbCtD
Caffeine—PRKDC—seminal vesicle—testicular cancer	0.00614	0.0532	CbGeAlD
Caffeine—PIK3CD—embryo—testicular cancer	0.00613	0.0531	CbGeAlD
Caffeine—PIK3CB—embryo—testicular cancer	0.00535	0.0463	CbGeAlD
Caffeine—PIK3CA—embryo—testicular cancer	0.00529	0.0458	CbGeAlD
Caffeine—PIK3CB—seminal vesicle—testicular cancer	0.00502	0.0435	CbGeAlD
Caffeine—PIK3CA—seminal vesicle—testicular cancer	0.00497	0.043	CbGeAlD
Caffeine—Necrotising colitis—Epirubicin—testicular cancer	0.00436	0.0546	CcSEcCtD
Caffeine—Necrotising colitis—Doxorubicin—testicular cancer	0.00403	0.0506	CcSEcCtD
Caffeine—ATM—female gonad—testicular cancer	0.00381	0.033	CbGeAlD
Caffeine—PIK3CB—gonad—testicular cancer	0.00363	0.0314	CbGeAlD
Caffeine—PRKDC—female gonad—testicular cancer	0.00361	0.0312	CbGeAlD
Caffeine—PIK3CA—gonad—testicular cancer	0.00359	0.0311	CbGeAlD
Caffeine—ATM—testis—testicular cancer	0.00338	0.0293	CbGeAlD
Caffeine—PIK3CD—female gonad—testicular cancer	0.00338	0.0293	CbGeAlD
Caffeine—PRKDC—testis—testicular cancer	0.0032	0.0277	CbGeAlD
Caffeine—Disseminated intravascular coagulation—Ifosfamide—testicular cancer	0.00318	0.0398	CcSEcCtD
Caffeine—PIK3CD—testis—testicular cancer	0.003	0.026	CbGeAlD
Caffeine—PIK3CB—female gonad—testicular cancer	0.00295	0.0255	CbGeAlD
Caffeine—PIK3CA—female gonad—testicular cancer	0.00292	0.0253	CbGeAlD
Caffeine—PIK3CB—testis—testicular cancer	0.00262	0.0227	CbGeAlD
Caffeine—RYR1—testis—testicular cancer	0.00259	0.0224	CbGeAlD
Caffeine—PIK3CA—testis—testicular cancer	0.00259	0.0224	CbGeAlD
Caffeine—ATM—lymph node—testicular cancer	0.00245	0.0212	CbGeAlD
Caffeine—PRKDC—lymph node—testicular cancer	0.00232	0.0201	CbGeAlD
Caffeine—ADORA2A—gonad—testicular cancer	0.0022	0.019	CbGeAlD
Caffeine—PIK3CD—lymph node—testicular cancer	0.00217	0.0188	CbGeAlD
Caffeine—Acidosis—Ifosfamide—testicular cancer	0.00205	0.0257	CcSEcCtD
Caffeine—ADORA2B—testis—testicular cancer	0.0019	0.0165	CbGeAlD
Caffeine—PIK3CB—lymph node—testicular cancer	0.0019	0.0164	CbGeAlD
Caffeine—PIK3CA—lymph node—testicular cancer	0.00188	0.0163	CbGeAlD
Caffeine—ADORA2A—testis—testicular cancer	0.00158	0.0137	CbGeAlD
Caffeine—PDE4B—gonad—testicular cancer	0.0014	0.0122	CbGeAlD
Caffeine—ADORA1—testis—testicular cancer	0.00137	0.0119	CbGeAlD
Caffeine—Deafness—Vinblastine—testicular cancer	0.00128	0.016	CcSEcCtD
Caffeine—Impaired healing—Methotrexate—testicular cancer	0.00124	0.0156	CcSEcCtD
Caffeine—CYP1B1—gonad—testicular cancer	0.0012	0.0104	CbGeAlD
Caffeine—Infection—Carboplatin—testicular cancer	0.00118	0.0148	CcSEcCtD
Caffeine—PDE4B—female gonad—testicular cancer	0.00114	0.00988	CbGeAlD
Caffeine—Sepsis—Dactinomycin—testicular cancer	0.00107	0.0135	CcSEcCtD
Caffeine—CYP2E1—seminal vesicle—testicular cancer	0.00107	0.0093	CbGeAlD
Caffeine—Injury—Bleomycin—testicular cancer	0.00105	0.0131	CcSEcCtD
Caffeine—Urine output increased—Ifosfamide—testicular cancer	0.00103	0.0129	CcSEcCtD
Caffeine—PDE4B—testis—testicular cancer	0.00101	0.00877	CbGeAlD
Caffeine—Pulmonary oedema—Ifosfamide—testicular cancer	0.00101	0.0127	CcSEcCtD
Caffeine—ADORA1—lymph node—testicular cancer	0.000992	0.00859	CbGeAlD
Caffeine—Sepsis—Ifosfamide—testicular cancer	0.000985	0.0123	CcSEcCtD
Caffeine—CYP1B1—female gonad—testicular cancer	0.000978	0.00847	CbGeAlD
Caffeine—Deafness—Ifosfamide—testicular cancer	0.000921	0.0115	CcSEcCtD
Caffeine—CYP1B1—testis—testicular cancer	0.000868	0.00751	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.000824	0.0103	CcSEcCtD
Caffeine—Deafness—Cisplatin—testicular cancer	0.000794	0.00995	CcSEcCtD
Caffeine—Haemoglobin—Vinblastine—testicular cancer	0.000793	0.00995	CcSEcCtD
Caffeine—Haemorrhage—Vinblastine—testicular cancer	0.000789	0.0099	CcSEcCtD
Caffeine—Sepsis—Etoposide—testicular cancer	0.000778	0.00975	CcSEcCtD
Caffeine—Blood creatinine increased—Ifosfamide—testicular cancer	0.000772	0.00967	CcSEcCtD
Caffeine—PDE4B—lymph node—testicular cancer	0.000734	0.00635	CbGeAlD
Caffeine—Hypercalcaemia—Epirubicin—testicular cancer	0.000723	0.00907	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00071	0.0089	CcSEcCtD
Caffeine—CYP1A1—female gonad—testicular cancer	0.000691	0.00599	CbGeAlD
Caffeine—Agitation—Chlorambucil—testicular cancer	0.000689	0.00864	CcSEcCtD
Caffeine—Irritability—Cisplatin—testicular cancer	0.000678	0.0085	CcSEcCtD
Caffeine—CYP3A5—female gonad—testicular cancer	0.000676	0.00586	CbGeAlD
Caffeine—Haemoglobin—Bleomycin—testicular cancer	0.00067	0.0084	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—testicular cancer	0.000669	0.00839	CcSEcCtD
Caffeine—Haemorrhage—Bleomycin—testicular cancer	0.000667	0.00836	CcSEcCtD
Caffeine—Blood creatinine increased—Cisplatin—testicular cancer	0.000665	0.00834	CcSEcCtD
Caffeine—CYP2C8—testis—testicular cancer	0.000664	0.00575	CbGeAlD
Caffeine—ABCB1—embryo—testicular cancer	0.000651	0.00564	CbGeAlD
Caffeine—Convulsion—Chlorambucil—testicular cancer	0.00065	0.00815	CcSEcCtD
Caffeine—Hyperglycaemia—Ifosfamide—testicular cancer	0.000642	0.00805	CcSEcCtD
Caffeine—Infestation NOS—Ifosfamide—testicular cancer	0.000635	0.00796	CcSEcCtD
Caffeine—Infestation—Ifosfamide—testicular cancer	0.000635	0.00796	CcSEcCtD
Caffeine—CYP1B1—lymph node—testicular cancer	0.000629	0.00545	CbGeAlD
Caffeine—Renal failure—Ifosfamide—testicular cancer	0.000624	0.00782	CcSEcCtD
Caffeine—ABCB1—seminal vesicle—testicular cancer	0.000612	0.0053	CbGeAlD
Caffeine—Infection—Chlorambucil—testicular cancer	0.000608	0.00762	CcSEcCtD
Caffeine—Convulsion—Vinblastine—testicular cancer	0.000595	0.00747	CcSEcCtD
Caffeine—Hypertension—Vinblastine—testicular cancer	0.000593	0.00744	CcSEcCtD
Caffeine—Haemoglobin—Ifosfamide—testicular cancer	0.000573	0.00718	CcSEcCtD
Caffeine—Haemorrhage—Ifosfamide—testicular cancer	0.00057	0.00714	CcSEcCtD
Caffeine—CYP2E1—testis—testicular cancer	0.000559	0.00484	CbGeAlD
Caffeine—Renal failure—Cisplatin—testicular cancer	0.000538	0.00674	CcSEcCtD
Caffeine—Cardiac disorder—Ifosfamide—testicular cancer	0.000529	0.00663	CcSEcCtD
Caffeine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000528	0.00662	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—testicular cancer	0.000528	0.00662	CcSEcCtD
Caffeine—Immune system disorder—Ifosfamide—testicular cancer	0.000515	0.00645	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—testicular cancer	0.000501	0.00629	CcSEcCtD
Caffeine—Infestation—Etoposide—testicular cancer	0.000501	0.00629	CcSEcCtD
Caffeine—CYP2D6—female gonad—testicular cancer	0.000499	0.00432	CbGeAlD
Caffeine—Malnutrition—Ifosfamide—testicular cancer	0.000496	0.00622	CcSEcCtD
Caffeine—Renal failure—Etoposide—testicular cancer	0.000493	0.00618	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—testicular cancer	0.000488	0.00612	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—testicular cancer	0.000485	0.00609	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—testicular cancer	0.000478	0.00599	CcSEcCtD
Caffeine—Infection—Bleomycin—testicular cancer	0.000471	0.0059	CcSEcCtD
Caffeine—Sepsis—Methotrexate—testicular cancer	0.000466	0.00584	CcSEcCtD
Caffeine—Cardiac disorder—Cisplatin—testicular cancer	0.000456	0.00572	CcSEcCtD
Caffeine—Agitation—Ifosfamide—testicular cancer	0.000456	0.00572	CcSEcCtD
Caffeine—Hypersensitivity—Chlorambucil—testicular cancer	0.000451	0.00565	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—testicular cancer	0.000447	0.00561	CcSEcCtD
Caffeine—CYP1A1—lymph node—testicular cancer	0.000445	0.00385	CbGeAlD
Caffeine—Immune system disorder—Cisplatin—testicular cancer	0.000444	0.00556	CcSEcCtD
Caffeine—CYP2D6—testis—testicular cancer	0.000443	0.00383	CbGeAlD
Caffeine—ABCB1—gonad—testicular cancer	0.000442	0.00383	CbGeAlD
Caffeine—Infection—Dactinomycin—testicular cancer	0.000439	0.0055	CcSEcCtD
Caffeine—Sepsis—Epirubicin—testicular cancer	0.000436	0.00547	CcSEcCtD
Caffeine—Convulsion—Ifosfamide—testicular cancer	0.00043	0.00539	CcSEcCtD
Caffeine—Hypertension—Ifosfamide—testicular cancer	0.000428	0.00537	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—testicular cancer	0.000428	0.00536	CcSEcCtD
Caffeine—Dyspnoea—Bleomycin—testicular cancer	0.000422	0.00529	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—testicular cancer	0.000418	0.00524	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—testicular cancer	0.000414	0.00519	CcSEcCtD
Caffeine—Hypersensitivity—Vinblastine—testicular cancer	0.000413	0.00518	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—testicular cancer	0.000407	0.0051	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—testicular cancer	0.000403	0.00506	CcSEcCtD
Caffeine—Infection—Ifosfamide—testicular cancer	0.000402	0.00504	CcSEcCtD
Caffeine—Nervous system disorder—Ifosfamide—testicular cancer	0.000397	0.00498	CcSEcCtD
Caffeine—Skin disorder—Ifosfamide—testicular cancer	0.000393	0.00493	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—testicular cancer	0.000374	0.00468	CcSEcCtD
Caffeine—Irritability—Methotrexate—testicular cancer	0.000372	0.00466	CcSEcCtD
Caffeine—Convulsion—Cisplatin—testicular cancer	0.000371	0.00465	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000365	0.00457	CcSEcCtD
Caffeine—PIK3CB—DAP12 signaling—FGFR3—testicular cancer	0.000362	0.00168	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000361	0.00168	CbGpPWpGaD
Caffeine—PIK3CD—B Cell Activation—FGFR3—testicular cancer	0.000361	0.00168	CbGpPWpGaD
Caffeine—Dyspnoea—Ifosfamide—testicular cancer	0.000361	0.00453	CcSEcCtD
Caffeine—PIK3CA—DAP12 interactions—KITLG—testicular cancer	0.000361	0.00168	CbGpPWpGaD
Caffeine—PIK3CA—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000361	0.00168	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR in disease—KITLG—testicular cancer	0.000361	0.00168	CbGpPWpGaD
Caffeine—ABCB1—female gonad—testicular cancer	0.000359	0.00311	CbGeAlD
Caffeine—PIK3CB—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000358	0.00167	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by FGFR in disease—KIT—testicular cancer	0.000358	0.00167	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 interactions—KIT—testicular cancer	0.000358	0.00167	CbGpPWpGaD
Caffeine—PIK3CD—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000358	0.00167	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by NGF—KITLG—testicular cancer	0.000358	0.00166	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR—KITLG—testicular cancer	0.000358	0.00166	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—INSL3—testicular cancer	0.000357	0.00166	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000356	0.00166	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by EGFR—KIT—testicular cancer	0.000355	0.00165	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000354	0.00165	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—INSL3—testicular cancer	0.000353	0.00164	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by ERBB4—KIT—testicular cancer	0.000353	0.00164	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by PDGF—KITLG—testicular cancer	0.000353	0.00164	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000352	0.00164	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by PDGF—KIT—testicular cancer	0.00035	0.00163	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00035	0.00438	CcSEcCtD
Caffeine—Hypersensitivity—Bleomycin—testicular cancer	0.000349	0.00438	CcSEcCtD
Caffeine—Infection—Cisplatin—testicular cancer	0.000347	0.00435	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—testicular cancer	0.000346	0.00433	CcSEcCtD
Caffeine—PIK3CD—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000346	0.00161	CbGpPWpGaD
Caffeine—Nervous system disorder—Cisplatin—testicular cancer	0.000342	0.00429	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—testicular cancer	0.000342	0.00428	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—testicular cancer	0.000341	0.00427	CcSEcCtD
Caffeine—PIK3CB—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00034	0.00158	CbGpPWpGaD
Caffeine—PIK3CB—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00034	0.00158	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 interactions—FGFR3—testicular cancer	0.00034	0.00158	CbGpPWpGaD
Caffeine—Convulsion—Etoposide—testicular cancer	0.000339	0.00426	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—testicular cancer	0.000339	0.00425	CcSEcCtD
Caffeine—PIK3CD—Innate Immune System—BCL10—testicular cancer	0.000338	0.00157	CbGpPWpGaD
Caffeine—Hypertension—Etoposide—testicular cancer	0.000338	0.00424	CcSEcCtD
Caffeine—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000338	0.00157	CbGpPWpGaD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000337	0.00423	CcSEcCtD
Caffeine—PIK3CB—Signaling by EGFR—FGFR3—testicular cancer	0.000337	0.00157	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signal transduction—KIT—testicular cancer	0.000337	0.00157	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by FGFR—KIT—testicular cancer	0.000335	0.00156	CbGpPWpGaD
Caffeine—Dry skin—Epirubicin—testicular cancer	0.000334	0.00419	CcSEcCtD
Caffeine—PIK3CB—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000334	0.00155	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—INSL3—testicular cancer	0.000334	0.00155	CbGpPWpGaD
Caffeine—PIK3CA—B Cell Activation—KITLG—testicular cancer	0.000334	0.00155	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by ERBB2—KIT—testicular cancer	0.000334	0.00155	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by PDGF—FGFR3—testicular cancer	0.000333	0.00155	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 signaling—KIT—testicular cancer	0.000332	0.00154	CbGpPWpGaD
Caffeine—PIK3CD—B Cell Activation—KIT—testicular cancer	0.000332	0.00154	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000327	0.00152	CbGpPWpGaD
Caffeine—Hypersensitivity—Dactinomycin—testicular cancer	0.000325	0.00408	CcSEcCtD
Caffeine—PIK3CD—Adaptive Immune System—BCL10—testicular cancer	0.000325	0.00151	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—INSL3—testicular cancer	0.000324	0.00151	CbGpPWpGaD
Caffeine—Gastritis—Epirubicin—testicular cancer	0.000323	0.00405	CcSEcCtD
Caffeine—PIK3CA—Signaling by SCF-KIT—FGFR3—testicular cancer	0.000322	0.0015	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—INSL3—testicular cancer	0.000321	0.00149	CbGpPWpGaD
Caffeine—CYP1B1—Biological oxidations—HPGDS—testicular cancer	0.00032	0.00149	CbGpPWpGaD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00032	0.00149	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—KITLG—testicular cancer	0.000319	0.00148	CbGpPWpGaD
Caffeine—ABCB1—testis—testicular cancer	0.000319	0.00276	CbGeAlD
Caffeine—Infection—Etoposide—testicular cancer	0.000318	0.00398	CcSEcCtD
Caffeine—PIK3CD—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000317	0.00148	CbGpPWpGaD
Caffeine—Blood creatinine increased—Doxorubicin—testicular cancer	0.000316	0.00396	CcSEcCtD
Caffeine—PIK3CB—B Cell Activation—FGFR3—testicular cancer	0.000315	0.00146	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by FGFR in disease—KIT—testicular cancer	0.000312	0.00145	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 interactions—KIT—testicular cancer	0.000312	0.00145	CbGpPWpGaD
Caffeine—PIK3CB—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000312	0.00145	CbGpPWpGaD
Caffeine—Tachycardia—Etoposide—testicular cancer	0.000312	0.00391	CcSEcCtD
Caffeine—PIK3CB—Signaling by NGF—KITLG—testicular cancer	0.000312	0.00145	CbGpPWpGaD
Caffeine—Dyspnoea—Cisplatin—testicular cancer	0.000311	0.0039	CcSEcCtD
Caffeine—Skin disorder—Etoposide—testicular cancer	0.000311	0.00389	CcSEcCtD
Caffeine—PIK3CB—Signaling by EGFR—KIT—testicular cancer	0.00031	0.00144	CbGpPWpGaD
Caffeine—Dry skin—Doxorubicin—testicular cancer	0.000309	0.00388	CcSEcCtD
Caffeine—PRKDC—Immune System—BCL10—testicular cancer	0.000308	0.00143	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000308	0.00143	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000308	0.00143	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000307	0.00143	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000307	0.00143	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by PDGF—KIT—testicular cancer	0.000305	0.00142	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—INSL3—testicular cancer	0.000303	0.00141	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by ERBB4—FGFR3—testicular cancer	0.000303	0.00141	CbGpPWpGaD
Caffeine—PIK3CB—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000301	0.0014	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000301	0.00378	CcSEcCtD
Caffeine—Infestation—Methotrexate—testicular cancer	0.0003	0.00376	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—testicular cancer	0.0003	0.00376	CcSEcCtD
Caffeine—Rash—Bleomycin—testicular cancer	0.000299	0.00374	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—testicular cancer	0.000299	0.00374	CcSEcCtD
Caffeine—Dermatitis—Bleomycin—testicular cancer	0.000298	0.00374	CcSEcCtD
Caffeine—Hypersensitivity—Ifosfamide—testicular cancer	0.000298	0.00374	CcSEcCtD
Caffeine—PIK3CA—Signaling by SCF-KIT—KIT—testicular cancer	0.000295	0.00137	CbGpPWpGaD
Caffeine—Renal failure—Methotrexate—testicular cancer	0.000295	0.0037	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—BCL10—testicular cancer	0.000295	0.00137	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signal transduction—FGFR3—testicular cancer	0.000289	0.00135	CbGpPWpGaD
Caffeine—PIK3CB—B Cell Activation—KIT—testicular cancer	0.000289	0.00134	CbGpPWpGaD
Caffeine—CYP3A7—Biological oxidations—HPGDS—testicular cancer	0.000289	0.00134	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR—FGFR3—testicular cancer	0.000288	0.00134	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by ERBB2—FGFR3—testicular cancer	0.000286	0.00133	CbGpPWpGaD
Caffeine—Dyspnoea—Etoposide—testicular cancer	0.000285	0.00357	CcSEcCtD
Caffeine—PIK3CA—DAP12 signaling—FGFR3—testicular cancer	0.000285	0.00133	CbGpPWpGaD
Caffeine—Hyperglycaemia—Epirubicin—testicular cancer	0.000284	0.00356	CcSEcCtD
Caffeine—PIK3CB—Adaptive Immune System—BCL10—testicular cancer	0.000283	0.00132	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000283	0.00131	CbGpPWpGaD
Caffeine—Infestation—Epirubicin—testicular cancer	0.000281	0.00352	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—testicular cancer	0.000281	0.00352	CcSEcCtD
Caffeine—PIK3CA—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000281	0.00131	CbGpPWpGaD
Caffeine—Rash—Dactinomycin—testicular cancer	0.000279	0.00349	CcSEcCtD
Caffeine—PIK3CA—Signaling by ERBB4—KIT—testicular cancer	0.000278	0.00129	CbGpPWpGaD
Caffeine—PIK3CB—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000277	0.00129	CbGpPWpGaD
Caffeine—Renal failure—Epirubicin—testicular cancer	0.000276	0.00346	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000276	0.00346	CcSEcCtD
Caffeine—ADORA2A—GPCR downstream signaling—INSL3—testicular cancer	0.000276	0.00128	CbGpPWpGaD
Caffeine—Haemoglobin—Methotrexate—testicular cancer	0.000271	0.0034	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—testicular cancer	0.00027	0.00338	CcSEcCtD
Caffeine—PIK3CA—DAP12 interactions—FGFR3—testicular cancer	0.000268	0.00125	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000268	0.00125	CbGpPWpGaD
Caffeine—PIK3CA—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000268	0.00125	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000268	0.00124	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by NGF—FGFR3—testicular cancer	0.000266	0.00124	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR—FGFR3—testicular cancer	0.000266	0.00124	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signal transduction—KIT—testicular cancer	0.000266	0.00123	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR—KIT—testicular cancer	0.000264	0.00123	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000264	0.00123	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000263	0.00122	CbGpPWpGaD
Caffeine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000263	0.0033	CcSEcCtD
Caffeine—PIK3CA—Signaling by ERBB2—KIT—testicular cancer	0.000263	0.00122	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by PDGF—FGFR3—testicular cancer	0.000262	0.00122	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 signaling—KIT—testicular cancer	0.000262	0.00122	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—INSL3—testicular cancer	0.000261	0.00121	CbGpPWpGaD
Caffeine—Infestation—Doxorubicin—testicular cancer	0.00026	0.00326	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—testicular cancer	0.00026	0.00326	CcSEcCtD
Caffeine—ATM—Cell Cycle—H2AFZ—testicular cancer	0.000258	0.0012	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000258	0.0012	CbGpPWpGaD
Caffeine—Hypersensitivity—Cisplatin—testicular cancer	0.000257	0.00322	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—testicular cancer	0.000256	0.0032	CcSEcCtD
Caffeine—Rash—Ifosfamide—testicular cancer	0.000255	0.0032	CcSEcCtD
Caffeine—Dermatitis—Ifosfamide—testicular cancer	0.000255	0.0032	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—testicular cancer	0.000254	0.00318	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—testicular cancer	0.000252	0.00316	CcSEcCtD
Caffeine—ADORA2A—Signaling by GPCR—INSL3—testicular cancer	0.00025	0.00116	CbGpPWpGaD
Caffeine—Cardiac disorder—Methotrexate—testicular cancer	0.00025	0.00314	CcSEcCtD
Caffeine—PIK3CA—B Cell Activation—FGFR3—testicular cancer	0.000248	0.00115	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—KIT—testicular cancer	0.000246	0.00114	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR in disease—KIT—testicular cancer	0.000246	0.00114	CbGpPWpGaD
Caffeine—PIK3CA—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000246	0.00114	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—KITLG—testicular cancer	0.000246	0.00114	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by NGF—KIT—testicular cancer	0.000244	0.00114	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR—KIT—testicular cancer	0.000244	0.00113	CbGpPWpGaD
Caffeine—Immune system disorder—Methotrexate—testicular cancer	0.000243	0.00305	CcSEcCtD
Caffeine—PIK3CA—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000242	0.00112	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by PDGF—KIT—testicular cancer	0.000241	0.00112	CbGpPWpGaD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000237	0.0011	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—FGFR3—testicular cancer	0.000237	0.0011	CbGpPWpGaD
Caffeine—Hypersensitivity—Etoposide—testicular cancer	0.000236	0.00295	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—testicular cancer	0.000235	0.00294	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—testicular cancer	0.000235	0.00294	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—testicular cancer	0.000234	0.00294	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—testicular cancer	0.000233	0.00293	CcSEcCtD
Caffeine—PIK3CA—Innate Immune System—BCL10—testicular cancer	0.000232	0.00108	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by NGF—FGFR3—testicular cancer	0.000232	0.00108	CbGpPWpGaD
Caffeine—ABCB1—lymph node—testicular cancer	0.000231	0.002	CbGeAlD
Caffeine—Immune system disorder—Epirubicin—testicular cancer	0.000228	0.00286	CcSEcCtD
Caffeine—PIK3CA—B Cell Activation—KIT—testicular cancer	0.000228	0.00106	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—INSL3—testicular cancer	0.000227	0.00106	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—INSL3—testicular cancer	0.000225	0.00105	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—BCL10—testicular cancer	0.000223	0.00104	CbGpPWpGaD
Caffeine—Rash—Cisplatin—testicular cancer	0.00022	0.00276	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—testicular cancer	0.00022	0.00276	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—testicular cancer	0.00022	0.00275	CcSEcCtD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000218	0.00101	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—KIT—testicular cancer	0.000218	0.00101	CbGpPWpGaD
Caffeine—Cardiac disorder—Doxorubicin—testicular cancer	0.000217	0.00272	CcSEcCtD
Caffeine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000215	0.001	CbGpPWpGaD
Caffeine—Nervousness—Epirubicin—testicular cancer	0.000213	0.00267	CcSEcCtD
Caffeine—PIK3CB—Signaling by NGF—KIT—testicular cancer	0.000213	0.00099	CbGpPWpGaD
Caffeine—Immune system disorder—Doxorubicin—testicular cancer	0.000211	0.00264	CcSEcCtD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000211	0.000981	CbGpPWpGaD
Caffeine—CYP2E1—Biological oxidations—HPGDS—testicular cancer	0.000209	0.000973	CbGpPWpGaD
Caffeine—CYP3A5—Biological oxidations—HPGDS—testicular cancer	0.000209	0.000971	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—KITLG—testicular cancer	0.000204	0.000949	CbGpPWpGaD
Caffeine—Convulsion—Methotrexate—testicular cancer	0.000203	0.00255	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—testicular cancer	0.000203	0.00255	CcSEcCtD
Caffeine—ADORA2A—Signaling by NGF—KITLG—testicular cancer	0.000203	0.000943	CbGpPWpGaD
Caffeine—Agitation—Epirubicin—testicular cancer	0.000202	0.00253	CcSEcCtD
Caffeine—Rash—Etoposide—testicular cancer	0.000202	0.00253	CcSEcCtD
Caffeine—Dermatitis—Etoposide—testicular cancer	0.000201	0.00253	CcSEcCtD
Caffeine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000197	0.000918	CbGpPWpGaD
Caffeine—Nervousness—Doxorubicin—testicular cancer	0.000197	0.00247	CcSEcCtD
Caffeine—CYP1A1—Biological oxidations—HPGDS—testicular cancer	0.000197	0.000917	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—BCL10—testicular cancer	0.000197	0.000917	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000196	0.000912	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—KITLG—testicular cancer	0.000196	0.000911	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—INSL3—testicular cancer	0.000192	0.000891	CbGpPWpGaD
Caffeine—Convulsion—Epirubicin—testicular cancer	0.00019	0.00239	CcSEcCtD
Caffeine—Infection—Methotrexate—testicular cancer	0.00019	0.00239	CcSEcCtD
Caffeine—Hypertension—Epirubicin—testicular cancer	0.00019	0.00238	CcSEcCtD
Caffeine—PDE4B—Signaling Pathways—INSL3—testicular cancer	0.000189	0.000881	CbGpPWpGaD
Caffeine—Nervous system disorder—Methotrexate—testicular cancer	0.000188	0.00235	CcSEcCtD
Caffeine—Agitation—Doxorubicin—testicular cancer	0.000187	0.00234	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—testicular cancer	0.000186	0.00233	CcSEcCtD
Caffeine—PRKDC—Immune System—KITLG—testicular cancer	0.000186	0.000863	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—FGFR3—testicular cancer	0.000183	0.000849	CbGpPWpGaD
Caffeine—CYP2C8—Biological oxidations—HPGDS—testicular cancer	0.000181	0.000841	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.00018	0.000837	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—INSL3—testicular cancer	0.000179	0.000834	CbGpPWpGaD
Caffeine—Infection—Epirubicin—testicular cancer	0.000178	0.00223	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—KITLG—testicular cancer	0.000178	0.000827	CbGpPWpGaD
Caffeine—Convulsion—Doxorubicin—testicular cancer	0.000176	0.00221	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—testicular cancer	0.000176	0.0022	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—testicular cancer	0.000175	0.0022	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—testicular cancer	0.000175	0.00219	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—testicular cancer	0.000174	0.00218	CcSEcCtD
Caffeine—PIK3CB—Immune System—BCL10—testicular cancer	0.000172	0.000799	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—KITLG—testicular cancer	0.000171	0.000794	CbGpPWpGaD
Caffeine—Dyspnoea—Methotrexate—testicular cancer	0.000171	0.00214	CcSEcCtD
Caffeine—PIK3CA—Signaling by NGF—KIT—testicular cancer	0.000168	0.00078	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000165	0.00207	CcSEcCtD
Caffeine—Infection—Doxorubicin—testicular cancer	0.000165	0.00207	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—testicular cancer	0.000163	0.00204	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—testicular cancer	0.000162	0.00203	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—testicular cancer	0.000161	0.00202	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—testicular cancer	0.00016	0.002	CcSEcCtD
Caffeine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000159	0.000737	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000155	0.00194	CcSEcCtD
Caffeine—PIK3CD—Innate Immune System—FGFR3—testicular cancer	0.000152	0.000705	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—FGFR3—testicular cancer	0.000151	0.000701	CbGpPWpGaD
Caffeine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000148	0.000691	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—INSL3—testicular cancer	0.000148	0.000688	CbGpPWpGaD
Caffeine—Dyspnoea—Doxorubicin—testicular cancer	0.000148	0.00185	CcSEcCtD
Caffeine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000147	0.000685	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—FGFR3—testicular cancer	0.000146	0.000677	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000145	0.000674	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000143	0.0018	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—testicular cancer	0.000141	0.00177	CcSEcCtD
Caffeine—PIK3CA—Innate Immune System—KITLG—testicular cancer	0.00014	0.000652	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—KIT—testicular cancer	0.000139	0.000648	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—KIT—testicular cancer	0.000138	0.000644	CbGpPWpGaD
Caffeine—PRKDC—Immune System—FGFR3—testicular cancer	0.000138	0.000642	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—HPGDS—testicular cancer	0.000137	0.000636	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—BCL10—testicular cancer	0.000135	0.00063	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—KITLG—testicular cancer	0.000135	0.000626	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—KIT—testicular cancer	0.000134	0.000622	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—FGFR3—testicular cancer	0.000132	0.000615	CbGpPWpGaD
Caffeine—Hypersensitivity—Epirubicin—testicular cancer	0.000132	0.00166	CcSEcCtD
Caffeine—PIK3CB—Adaptive Immune System—FGFR3—testicular cancer	0.000127	0.00059	CbGpPWpGaD
Caffeine—PRKDC—Immune System—KIT—testicular cancer	0.000127	0.000589	CbGpPWpGaD
Caffeine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000126	0.000585	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000123	0.000572	CbGpPWpGaD
Caffeine—Hypersensitivity—Doxorubicin—testicular cancer	0.000122	0.00153	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—KIT—testicular cancer	0.000121	0.000564	CbGpPWpGaD
Caffeine—Rash—Methotrexate—testicular cancer	0.000121	0.00151	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—testicular cancer	0.000121	0.00151	CcSEcCtD
Caffeine—PIK3CD—Disease—H2AFZ—testicular cancer	0.000119	0.000555	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—HPGDS—testicular cancer	0.000119	0.000554	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KITLG—testicular cancer	0.000119	0.000553	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—KIT—testicular cancer	0.000117	0.000542	CbGpPWpGaD
Caffeine—Rash—Epirubicin—testicular cancer	0.000113	0.00142	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—testicular cancer	0.000113	0.00142	CcSEcCtD
Caffeine—PIK3CD—Disease—KITLG—testicular cancer	0.00011	0.00051	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000105	0.00049	CbGpPWpGaD
Caffeine—Rash—Doxorubicin—testicular cancer	0.000105	0.00131	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—testicular cancer	0.000104	0.00131	CcSEcCtD
Caffeine—PIK3CA—Innate Immune System—FGFR3—testicular cancer	0.000104	0.000484	CbGpPWpGaD
Caffeine—PIK3CB—Disease—H2AFZ—testicular cancer	0.000104	0.000484	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KITLG—testicular cancer	0.000104	0.000482	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—FGFR3—testicular cancer	0.0001	0.000465	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—STK11—testicular cancer	9.93e-05	0.000462	CbGpPWpGaD
Caffeine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	9.71e-05	0.000451	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KITLG—testicular cancer	9.56e-05	0.000445	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—KIT—testicular cancer	9.56e-05	0.000445	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—HPGDS—testicular cancer	9.39e-05	0.000437	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—KIT—testicular cancer	9.18e-05	0.000427	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—FGFR3—testicular cancer	8.83e-05	0.000411	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—STK11—testicular cancer	8.66e-05	0.000403	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—H2AFZ—testicular cancer	8.35e-05	0.000388	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—STK11—testicular cancer	8.3e-05	0.000386	CbGpPWpGaD
Caffeine—PIK3CA—Disease—H2AFZ—testicular cancer	8.19e-05	0.000381	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KITLG—testicular cancer	8.16e-05	0.00038	CbGpPWpGaD
Caffeine—PIK3CD—Disease—FGFR3—testicular cancer	8.16e-05	0.000379	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KIT—testicular cancer	8.11e-05	0.000377	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—FGFR3—testicular cancer	7.7e-05	0.000358	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KITLG—testicular cancer	7.68e-05	0.000357	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.57e-05	0.000352	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KITLG—testicular cancer	7.54e-05	0.000351	CbGpPWpGaD
Caffeine—PIK3CD—Disease—KIT—testicular cancer	7.49e-05	0.000348	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—H2AFZ—testicular cancer	7.28e-05	0.000339	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—STK11—testicular cancer	7.24e-05	0.000337	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—H2AFZ—testicular cancer	7.21e-05	0.000336	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—STK11—testicular cancer	7.17e-05	0.000334	CbGpPWpGaD
Caffeine—PIK3CB—Disease—FGFR3—testicular cancer	7.11e-05	0.000331	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KIT—testicular cancer	7.07e-05	0.000329	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.94e-05	0.000323	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—STK11—testicular cancer	6.82e-05	0.000317	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KITLG—testicular cancer	6.7e-05	0.000312	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KITLG—testicular cancer	6.64e-05	0.000309	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KIT—testicular cancer	6.53e-05	0.000304	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—H2AFZ—testicular cancer	6.13e-05	0.000285	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—STK11—testicular cancer	6.1e-05	0.000284	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—FGFR3—testicular cancer	6.07e-05	0.000282	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—H2AFZ—testicular cancer	6.06e-05	0.000282	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STK11—testicular cancer	6.03e-05	0.00028	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—H2AFZ—testicular cancer	5.74e-05	0.000267	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—FGFR3—testicular cancer	5.71e-05	0.000266	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STK11—testicular cancer	5.7e-05	0.000265	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.65e-05	0.000263	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KITLG—testicular cancer	5.64e-05	0.000262	CbGpPWpGaD
Caffeine—PIK3CA—Disease—FGFR3—testicular cancer	5.6e-05	0.000261	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KITLG—testicular cancer	5.58e-05	0.000259	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KIT—testicular cancer	5.57e-05	0.000259	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—HPGDS—testicular cancer	5.48e-05	0.000255	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KITLG—testicular cancer	5.28e-05	0.000245	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KIT—testicular cancer	5.24e-05	0.000244	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KIT—testicular cancer	5.14e-05	0.000239	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—FGFR3—testicular cancer	4.98e-05	0.000232	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—HPGDS—testicular cancer	4.94e-05	0.00023	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—FGFR3—testicular cancer	4.93e-05	0.000229	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.83e-05	0.000225	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—H2AFZ—testicular cancer	4.74e-05	0.00022	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STK11—testicular cancer	4.71e-05	0.000219	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KIT—testicular cancer	4.57e-05	0.000213	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KIT—testicular cancer	4.53e-05	0.000211	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KITLG—testicular cancer	4.36e-05	0.000203	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—FGFR3—testicular cancer	4.19e-05	0.000195	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—FGFR3—testicular cancer	4.14e-05	0.000193	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—STK11—testicular cancer	3.98e-05	0.000185	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FGFR3—testicular cancer	3.92e-05	0.000182	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KIT—testicular cancer	3.85e-05	0.000179	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KIT—testicular cancer	3.8e-05	0.000177	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KIT—testicular cancer	3.6e-05	0.000168	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—STK11—testicular cancer	3.59e-05	0.000167	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HPGDS—testicular cancer	3.58e-05	0.000166	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HPGDS—testicular cancer	3.57e-05	0.000166	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HPGDS—testicular cancer	3.37e-05	0.000157	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FGFR3—testicular cancer	3.24e-05	0.000151	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HPGDS—testicular cancer	3.09e-05	0.000144	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KIT—testicular cancer	2.97e-05	0.000138	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HPGDS—testicular cancer	2.69e-05	0.000125	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—STK11—testicular cancer	2.6e-05	0.000121	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—STK11—testicular cancer	2.59e-05	0.000121	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HPGDS—testicular cancer	2.54e-05	0.000118	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HPGDS—testicular cancer	2.52e-05	0.000117	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—STK11—testicular cancer	2.45e-05	0.000114	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—STK11—testicular cancer	2.25e-05	0.000105	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HPGDS—testicular cancer	2.15e-05	0.0001	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—STK11—testicular cancer	1.96e-05	9.11e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—STK11—testicular cancer	1.84e-05	8.58e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—STK11—testicular cancer	1.83e-05	8.51e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.66e-05	7.72e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—STK11—testicular cancer	1.56e-05	7.27e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—STK11—testicular cancer	1.21e-05	5.61e-05	CbGpPWpGaD
